osteoarthritis of knee. M17 =Gonarthrosis [arthrosis of knee]
Conditions
Interventions
The current double-blind RTC was conducted on 100 eligible patients with osteoarthritis randomly assigned to 2 groups of intervention (Shafa ointment) and control (diclofenac ointment) using the block
Sponsors
Booali Pharmaceutical Company
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: age range 18 to 50 years old; clinical symptoms including bone pain when pressure applied; bone enlargement; lack of local heating; crepitus ? limitation of knee range of motion ; feeling moderate knee pain based on the Western Ontario & McMaster Universities Osteoarthritis (WOMAC) index.
Exclusion criteria
Exclusion criteria: lack of patient’s cooperation or willingness; acute knee osteoarthritis; secondary osteoarthritis; disabling diseases such as osteoarticular and infectious diseases; severe pain that required another sedative agent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of knee pain. Timepoint: befor intervention, 7 weeks after start of treatment. Method of measurement: womac questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Joint stiffness. Timepoint: befor intervention, 7 weeks after start of treatment. Method of measurement: womac questionnaire.;Restriction of movement. Timepoint: befor intervention, 7 weeks after start of treatment. Method of measurement: womac questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contact?Alireza Masumi
Bu ali Pharmaceutical Company
Outcome results
None listed